Tumor heterogeneity in breast cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Traditional teachings state that monoclonality is a sine qua non of malignancy. Tumor heterogeneity at first glance flies in the face of clonal origin of tumors. However, heterogeneity represents clonal evolution and adaption to adverse environment and is a cardinal feature of all life forms including tumors. The major concern is that these adaptations could interfere with therapies and affect patient outcomes. Variability in clinical presentation, tumor histology, response to treatment and outcomes have been long recognized by clinicians and pathologists. In this review, we revisit this old friend (or, perhaps more correctly, a foe) and document that heterogeneity that exists at all, clinical, histological and molecular, levels and briefly outline the strategies that have been used by clinicians and pathologists to tackle this complicated issue.

Original languageEnglish (US)
Title of host publicationMolecular Pathology of Breast Cancer
PublisherSpringer International Publishing
Pages121-132
Number of pages12
ISBN (Electronic)9783319417615
ISBN (Print)9783319417592
DOIs
StatePublished - Jan 1 2016

Fingerprint

Breast Neoplasms
Neoplasms
Clonal Evolution
Histology
Teaching
Pathologists
Therapeutics

Keywords

  • Breast cancer
  • Tumor heterogeneity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Badve, S. (2016). Tumor heterogeneity in breast cancer. In Molecular Pathology of Breast Cancer (pp. 121-132). Springer International Publishing. https://doi.org/10.1007/978-3-319-41761-5_9

Tumor heterogeneity in breast cancer. / Badve, Sunil.

Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. p. 121-132.

Research output: Chapter in Book/Report/Conference proceedingChapter

Badve, S 2016, Tumor heterogeneity in breast cancer. in Molecular Pathology of Breast Cancer. Springer International Publishing, pp. 121-132. https://doi.org/10.1007/978-3-319-41761-5_9
Badve S. Tumor heterogeneity in breast cancer. In Molecular Pathology of Breast Cancer. Springer International Publishing. 2016. p. 121-132 https://doi.org/10.1007/978-3-319-41761-5_9
Badve, Sunil. / Tumor heterogeneity in breast cancer. Molecular Pathology of Breast Cancer. Springer International Publishing, 2016. pp. 121-132
@inbook{2a5e5e864bf54c0a9e7362c39a45e8ac,
title = "Tumor heterogeneity in breast cancer",
abstract = "Traditional teachings state that monoclonality is a sine qua non of malignancy. Tumor heterogeneity at first glance flies in the face of clonal origin of tumors. However, heterogeneity represents clonal evolution and adaption to adverse environment and is a cardinal feature of all life forms including tumors. The major concern is that these adaptations could interfere with therapies and affect patient outcomes. Variability in clinical presentation, tumor histology, response to treatment and outcomes have been long recognized by clinicians and pathologists. In this review, we revisit this old friend (or, perhaps more correctly, a foe) and document that heterogeneity that exists at all, clinical, histological and molecular, levels and briefly outline the strategies that have been used by clinicians and pathologists to tackle this complicated issue.",
keywords = "Breast cancer, Tumor heterogeneity",
author = "Sunil Badve",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-41761-5_9",
language = "English (US)",
isbn = "9783319417592",
pages = "121--132",
booktitle = "Molecular Pathology of Breast Cancer",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Tumor heterogeneity in breast cancer

AU - Badve, Sunil

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Traditional teachings state that monoclonality is a sine qua non of malignancy. Tumor heterogeneity at first glance flies in the face of clonal origin of tumors. However, heterogeneity represents clonal evolution and adaption to adverse environment and is a cardinal feature of all life forms including tumors. The major concern is that these adaptations could interfere with therapies and affect patient outcomes. Variability in clinical presentation, tumor histology, response to treatment and outcomes have been long recognized by clinicians and pathologists. In this review, we revisit this old friend (or, perhaps more correctly, a foe) and document that heterogeneity that exists at all, clinical, histological and molecular, levels and briefly outline the strategies that have been used by clinicians and pathologists to tackle this complicated issue.

AB - Traditional teachings state that monoclonality is a sine qua non of malignancy. Tumor heterogeneity at first glance flies in the face of clonal origin of tumors. However, heterogeneity represents clonal evolution and adaption to adverse environment and is a cardinal feature of all life forms including tumors. The major concern is that these adaptations could interfere with therapies and affect patient outcomes. Variability in clinical presentation, tumor histology, response to treatment and outcomes have been long recognized by clinicians and pathologists. In this review, we revisit this old friend (or, perhaps more correctly, a foe) and document that heterogeneity that exists at all, clinical, histological and molecular, levels and briefly outline the strategies that have been used by clinicians and pathologists to tackle this complicated issue.

KW - Breast cancer

KW - Tumor heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=85009654777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009654777&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-41761-5_9

DO - 10.1007/978-3-319-41761-5_9

M3 - Chapter

SN - 9783319417592

SP - 121

EP - 132

BT - Molecular Pathology of Breast Cancer

PB - Springer International Publishing

ER -